Lung transplantation for patients with end-stage lung disease is associated with improved survival and quality of life [1,2]. The median post-lung transplant survival in the current era is approximately 6 years, as compared to a median survival of 4 years among those transplanted between 1990 and 1998 [3]. However, the survival following lung transplantation remains significantly worse as compared to other solid organ transplants. There are certain unique features of lung transplantation that predispose recipients to a multitude of surgical and medical complications.

No abstract

No abstract

La neumonía eosinofílica crónica es una enfermedad poco conocida, caracterizada por un deterioro respiratorio progresivo mayor de un mes de evolución, con presencia de infiltrados pulmonares y eosinofília. Se han reportado varios casos de asociación con sulfasalazina en enfermedad inflamatoria intestinal. Describimos un caso de neumonía eosinofílica crónica en un paciente con antecedente de artritis reumatoide en tratamiento con sulfasalazina.